FDA clears advanced smartwatch capable of detecting AFib

Withings, an international healthcare technology company, has received FDA clearance for ScanWatch, its wearable solution that can track a person’s heart rate, identify signs of atrial fibrillation (AFib) and more.  ScanWatch will be available in North America in November. It was launched in Europe in 2020.  “ScanWatch has been clinically…

Read the full article here

Related Articles